RxDoctor Payments Data

Jeffrey Giuliani, MD

Orthopaedic Surgery · Fairfax, VANPI 1538276357

Payments from drug & device makers

$27,542in general payments, 2019–2025

Across 132 payments — averaging $208.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$16K
  • Arthrex$5K
  • Supreme Orthopedic Systems, LLC$2K
  • Arcuro Medical Inc$2K
  • Smith+Nephew$1K
  • Ossio Inc$1K
  • plus $932 from 11 others

What the payments were for

  • Consulting fees$15,40056%
  • Speaking & faculty fees$2,0007%
  • Travel & lodging$4,35216%
  • Food & beverage$5,61920%
  • Education$1711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker23$15,707
Arthrex62$4,743
Supreme Orthopedic Systems, LLC23$2,473
Arcuro Medical Inc1$1,500
Smith+Nephew10$1,187
Ossio Inc1$1,000
Linvatec Corporation2$269
Zimmer Biomet1$144
Xiros Inc1$135
Abanza Inc.1$119
Axogen1$81
Lima USA, Inc.1$43
Davol Inc.1$42
Inari Medical, Inc.1$42
FX Shoulder Solutions, Inc1$27
Vericel Corporation1$21
Orthofix Medical, Inc.1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,542 in reported general payments places this provider in the 80th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$95,029
Medicare patients
153
Services billed
581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron18$82
Oxycodone Hcl19$80
Meloxicam30$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →